Viral Hepatitis

A Post from the ADAP Crisis Task Force

ADAP Crisis Task Force Announces Groundbreaking Agreement with AbbVie for Hepatitis C Treatment Viekira Pak ™ FOR IMMEDIATE RELEASE Contact:  Britten Pund 202-434-8090  January 15, 2015, Washington, DC – The ADAP Crisis Task Force (Task Force) has reached a new pricing agreement between AbbVie and AIDS Drug Assistance Programs (ADAPs) for Viekira Pak (ombitasvir/paritaprevir/ritonavir tablets;…

Report of 2013 Progress on Viral Hepatitis Action Plan


This week, we release the third annual report of progress made in implementing the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis (Action Plan). The 2013 report [PDF 655KB], compiled by the HHS Office of HIV/AIDS and Infectious Disease Policy, spotlights several key accomplishments under each of the Action Plan’s six priority areas…

NIH Announces Funding for New Technologies for Viral Hepatitis

nih logo

The National Institutes of Health (NIH) has issued a funding opportunity announcement (FOA) to encourage small businesses to address viral hepatitis research opportunities delineated in the Action Plan for the Prevention, Care, and Treatment of Viral Hepatitis (Action Plan) [PDF 2MB]. The announcement of a Small Business Innovation Research (SBIR) grant entitled New Technologies for Viral…

Implementing the Viral Hepatitis Action Plan: The Role of Community Leadership

Hep B United logo

The development of the updated national Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis: 2014-2016 [PDF 2.01MB] (Action Plan) in April 2014 marked a new opportunity for community-based organizations invested in eliminating hepatitis B and C disparities, to explore what activities federal agencies are planning to undertake and how the organizations and agencies…

Access to Hepatitis C Therapy Listening Session with Community Stakeholders

Ronald Valdiserri

Last month, the Department of Health and Human Services (HHS) convened a listening session on the important issue of access to curative treatment for hepatitis C virus infection. While the advent of more effective, second-generation direct-acting antivirals for the treatment of hepatitis C represents a tremendous scientific accomplishment and a potential public health triumph, community…

Viral Hepatitis Prevention Coordinators, a Vital CDC Program Helping to Achieve the Goals of the Viral Hepatitis Action Plan

CDC Logo

Viral Hepatitis Prevention Coordinators (VHPCs) are vital to the implementation of the nation’s Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis, and ultimately, achievement of 3 of the national goals of reducing viral hepatitis transmission and disease: Increase the proportion of persons who are aware of their hepatitis B virus (HBV) infection,…

Viral Hepatitis Issues Examined at 2014 American Public Health Association (APHA) Annual Meeting


Hepatitis B and C were among the important public health issues examined at the recent annual meeting of the American Public Health Association (APHA) . The annual meeting, held November 14-19, 2014 in New Orleans, Louisiana, is one of the nation’s largest gatherings of public health professionals, including clinicians, researchers, policy makers, students, and others committed…

Looking Ahead to 2015


As 2014 comes to a close and we prepare to celebrate the potential of the new year, Dr. Ronald Valdiserri, Deputy Assistant Secretary for Health, Infectious Diseases, shares his thoughts on the year ahead in this video message. Dr. Valdiserri, who leads efforts to implement the National HIV/AIDS Strategy and the Viral Hepatitis Action Plan,…